Publications

5808 Results

A phase II trial of azacitidine (NSC-102816) and gemtuzumab ozogamicin (NSC0720568) as induction and post-remission therapy in patients of age 60 and older with previusly untreated non-M3 acute myeloid leukemia (SWOG S0703): Report on the poor risk patients

Authors
S Nand;M Othus;J Godwin;C Willman;TH Norwood;HP Erba;DS Howard;SE Coutre;F Appelbaum
Journal / Conference
Blood 120(21):abst.3584; American Society of Hematology Annual Meeting, poster;
Year
2012
Research Committee(s)
Leukemia
Study Number(s)
S0703

SWOG study S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukemia

Authors
A Advani;S McDonough;SE Coutre;B Wood;J Radich;MP Mims;M O'Donnell;S Elkins;MW Becker;M Othus;F Appelbaum
Journal / Conference
Blood 120(21):abst.2603; American Society of Hematology Annual Meeting, poster;
Year
2012
Research Committee(s)
Leukemia
Study Number(s)
S0910

Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation and replication in SWOG and LYSA

Authors
JL Kelly;G Salles;B Goldman;R Fisher;O Casasnovas;O Press;D Maloney;P Soubeyran;L Rimsza;M Leblanc;H Tilly;J Friedberg
Journal / Conference
Blood 120(21):abst.2712; American Society of Hematology, poster;
Year
2012
Research Committee(s)
Lymphoma
Study Number(s)
S0016, SWOG-8947, S9800, S9911

A scoring system of prediction of FLT3-ITD positivity in patients with newly diagnosed acute myeloid leukemia: a SWOG, Fred Hutchinson and M.D. Anderson Cancer Center study

Authors
F Ostronoff;M Othus;S Meshinchi;F Appelbaum;E Estey
Journal / Conference
Blood 120(21):abst. 2590; American Society of Hematology Annual Meeting, poster;
Year
2012
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-9031, SWOG-9333, SWOG-9500

Declining rates of treatment-related mortality recent in patients with newly-diagnosed AML given "intense" induction regimens: a report from SWOG and MD Anderson

Authors
M Othus;H Kantarjian;S Petersdorf;F Ravandi;J Godwin;J Cortes;S Pierce;H Erba;S Faderl;F Appelbaum;E Estey
Journal / Conference
Blood 120(21):abst. 129; American Society of Hematology Annual Meeting, oral;
Year
2012
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

Single-cell network profiling (SCNP)-based classifier to predict response to induction therapy in elderlly patients with acute myeloid leukemia (AML): validation in two independent sample sets from ECOG and SWOG trials

Authors
A Cesano;C Willman;K Kopecky;U Gayko;S Putta;B Louie;M Westfall;N Purvis;D Spellmeyer;C Marimpietri;J Hackett;J Shi;E Paietta;M Tallman;L Cripe;S Atwater;F Appelbaum;J Radich
Journal / Conference
Blood 120(21):abst.2489; American Society of Hematology Annual Meeting, poster;
Year
2012
Research Committee(s)
Leukemia
Study Number(s)
S0112, S0301, SWOG-9031, SWOG-9333

Prognostic significance of the French-American-British (FAB) morphologic subclassification of "acute myeloid leukemia, not otherwise specified" in the 2008 WHO classification: analysis of 5,848 newly diagnosed patients from HOVON, MRC, SWOG, and MD Anderson Cancer Center

Authors
R Walter;M Othus;AK Burnett;B Lowenberg;H Kantarjian;G Ossenkoppele;RK Hills;K van Montfort;F Ravandi;S Pierce;F Appelbaum;E Estey
Journal / Conference
Blood 120(21)abst. 540; American Society of Hematology Annual Meeting, oral;
Year
2012
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9333, SWOG-9500, S9617

MYC protein expression, but not high grade morphology, is associated with poor outcome in non-Burkitt diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study

Authors
JR Cook;B Goldman;RR Tubbs;L Rimsza;M LeBlanc;P Stiff;RI Fisher
Journal / Conference
Blood 120(21):abst.543; American Society of Hematology Annual Meeting, oral;
Year
2012
Research Committee(s)
Lymphoma
Study Number(s)
S9704

Differences in outcomes in males and females with diffuse large B-cell lymphoma and follicular lymphoma treated with rituximab (ECOG E4494, CALGB 9793, SWOG E4494, E1496)

Authors
T Habermann;F Hong;V Morrison;S Dakhil;SO Jacobson;JK Weick;S Frankel;R Gascoyne;R Fisher;B Cheson;EA Weller;BS Kahl;SJ Horning;BA Peterson;HS Hochster
Journal / Conference
Blood 120(21):abst. 3535; American Society of Hematology Annual Meeting, poster;
Year
2012
Research Committee(s)
Lymphoma
Study Number(s)
E4494

Associations of serum sex steroid hormones and 5a-androstane-3a,17B-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride

Authors
A Kristal;C Till;C Tangen;PJ Goodman;M Neuhouser;F Stanczyk;LW Chu;SK Patel;WD Figg;A van Bokhoven;SM Lippman;A Hsing
Journal / Conference
Cancer Epidemiology Biomarkers and Prevention 21(10):1823-1832
Year
2012
Research Committee(s)
Cancer Control
PMID
PMID22879203
PMC
PMC3467348
Study Number(s)
SWOG-9217